MSH|^~\&|||||20131130103934-0700||VXU^V04^VXU_V04|742380-A1.1.4239|P|2.5.1|PID|1||742380-A1.1^^^OIS-TEST^MR||Peters^Drystan^Clayland^^^^L|Frontier^Esta|20091207|M||2106-3^White^HL70005|151 Barren St^^Caseville^MI^48725^USA^P||^PRN^PH^^^989^6041489|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|NK1|1|Frontier^Esta|MTH^Mother^HL70063|ORC|RE||R30I1.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z1364WM||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130103934-0700||VXU^V04^VXU_V04|742380-A1.2.4365|P|2.5.1|PID|1||742380-A1.2^^^OIS-TEST^MR||Pacific^Menenius^^^^^L||19461126|M||2054-5^Black or African-American^HL70005|282 Dick St^^Grosse Pointe Farms^MI^48230^USA^P||^PRN^PH^^^313^2843583|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||X25M2.3^OIS|RXA|0|1|20131130||115^Tdap^CVX|1|mL^milliliters^UCUM||00^Administered^NIP001||||||W09XZ||SKB^GlaxoSmithKline^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|115^Td/Tdap^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120124||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130103934-0700||VXU^V04^VXU_V04|742380-A1.3.4386|P|2.5.1|PID|1||742380-A1.3^^^OIS-TEST^MR||Plymouth^Ottavia^Noelani^^^^L||20001120|F||2106-3^White^HL70005|71 Metcalfe Cir^^Lupton^MI^48635^USA^P||^PRN^PH^^^989^9402502|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||W82C3.3^OIS|RXA|0|1|20131130||118^HPV^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&|||||20131130103934-0700||VXU^V04^VXU_V04|742380-A1.4.4389|P|2.5.1|PID|1||742380-A1.4^^^OIS-TEST^MR||Richland^Wakanda^Rishona^^^^L||20001205|F||2054-5^Black or African-American^HL70005|336 Ross St^^Grand Blanc^MI^48480^USA^P||^PRN^PH^^^810^8458322|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1||||||||||||N|ORC|RE||N71J4.3^OIS|RXA|0|1|20131130||115^Tdap^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&|||||20131130103934-0700||VXU^V04^VXU_V04|742380-A1.5.4392|P|2.5.1|PID|1||742380-A1.5^^^OIS-TEST^MR||Delaware^Vidya^Fairley^^^^L||20091205|F||2054-5^Black or African-American^HL70005|183 Huron Ln^^Mesick^MI^49668^USA^P||^PRN^PH^^^231^6100483|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||D00M5.3^OIS|RXA|0|1|20131130||03^MMR^CVX|999||||||||||||00^Parental Decision^NIP002||RE|A|MSH|^~\&|||||20131130103934-0700||VXU^V04^VXU_V04|742380-A1.6.4394|P|2.5.1|PID|1||742380-A1.6^^^OIS-TEST^MR||Gooding^Eurwyn^Avon^^^^L||20001130|M||2106-3^White^HL70005|302 Kjerulf Cir^^Kaleva^MI^49645^USA^P||^PRN^PH^^^231^8709268|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||W35L6.3^OIS|RXA|0|1|20131130||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|38907003^Varicella infection^SCT||||||F|MSH|^~\&|||||20131130103934-0700||VXU^V04^VXU_V04|742380-A1.7.4397|P|2.5.1|PID|1||742380-A1.7^^^OIS-TEST^MR||Jonson^Zoie^^^^^L||20091124|F||2106-3^White^HL70005|29 Skag Ln^^Independence Township^MI^48346^USA^P||^PRN^PH^^^248^7897207|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||P13I7.1^OIS|RXA|0|1|20101122||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101122||||||F|ORC|RE||P13I7.2^OIS|RXA|0|1|20110623||21^Varicella^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||P13I7.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||D9080OG||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|